EVAX logo
Evaxion Biotech A/S(EVAX)
Closing price · checked 4:32 PM ESTAbout this dataData status
$2.91▲0.05 (1.75%)Earnings · Nov 19
After Hours:$2.91+0.00 (+0.00%)

Consensus

Buy4.00 / 52 ratings · Buy 2

Price vs analyst targets

Revenue and EPS estimates

ReportedConsensus estimates
Fiscal periodFY2023Dec '23FY2024Dec '24FY2025Dec '25FY2026Dec '26FY2027Dec '27FY2028Dec '28FY2029Dec '29FY2030Dec '30
Revenue (M)0.33.37.515.86.215.441.650.8
Growth YoY–+1102.9%+124.5%+110.5%−60.6%+147.5%+170.0%+22.0%
High estimate0.3–7.515.86.215.741.650.8
Low estimate0.3–7.515.86.215.141.650.8
Analysts3–223312
EPS, adjusted−16.52−3.90−1.06−0.04−0.020.030.050.06
Growth YoY–n/mn/mn/mn/mn/m+66.7%+20.0%
High estimate–––−0.04−0.020.240.050.06
Low estimate–––−0.04−0.02−0.180.050.06
Analysts–––11211

Consensus mean of analyst estimates. EPS is adjusted (street) EPS, the basis analysts forecast; annual actuals are the sum of the four reported quarters. Growth compares with the same period a year earlier; n/m where the prior period was a loss.

Brokers

3 firms active in the last 12 months
FirmAnalystRatingPrev ratingTargetPrev targetChgUpsideDate
HC Wainwright & Co.–BuyBuy––––Apr 24
Lake Street–BuyBuy$9.00$11.00−18%+208%Mar 9
Maxim Group–––$10.00––+242%Feb 19

Latest analyst action Page refreshed hourly; analyst feeds refreshed dailyAbout this data

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.